Murray Dallan sold SRPT
March 7, 2025 · Form 4 insider transaction
Murray Dallan sold 8,613 shares of Sarepta Therapeutics, Inc. at $103.70 per share, a transaction worth $893.2K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,613
Price
$103.70
Total value
$893.2K
InsiderMurray Dallan
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 7, 2025
Filing dateMarch 10, 2025
Shares owned after28,159
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 6, 2023.